Clinical and economic outcomes from a community hospital's antimicrobial stewardship program


      Data from community antimicrobial stewardship programs (ASPs) are limited. We describe clinical and economic outcomes from the first year of our hospital's ASP.


      The ASP team comprised 2 infectious disease physicians and 3 intensive care unit pharmacists. The team prospectively audited the new starts and weekly use of 8 target antimicrobials: aztreonam, caspofungin, daptomycin, ertapenem, linezolid, meropenem, tigecycline, and voriconazole. Using administrative data, outcomes from the first year of the program, including death within 30 days of hospitalization, readmission within 30 days of discharge, and development of Clostridium difficile infection (CDI), were compared with outcomes from a similar period before institution of the program.


      A total of 510 antimicrobial orders were reviewed, of which 323 (63%) were appropriate, 94 (18%) prompted deescalation, 61 (12%) were denied, and 27 (5%) led to formal consultation with an infectious disease physician. On multivariate analysis, implementation of the ASP was associated with an approximate 50% reduction in the odds of developing CDI (odds ratio, 0.46; 95% confidence interval, 0.25-0.82). The ASP was not associated with decreased mortality at 30 days after discharge or readmission rate. The antimicrobial cost per patient-day decreased by 13.3%, from $10.16 to $8.81. The antimicrobial budget decreased by 15.2%, resulting in a total savings of $228,911. There was a 25.4% decrease in defined daily doses of the target antimicrobials.


      Implementation of the ASP was associated with significant reductions in CDI rate, antimicrobial use, and pharmacy costs.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • McGowan Jr., J.E.
        Minimizing antimicrobial resistance: the key role of the infectious diseases physician.
        Clin Infect Dis. 2004; 38: 939-942
        • National Nosocomial Infections Surveillance System
        National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004.
        Am J Infect Control. 2004; 32: 470-485
        • Dellit T.H.
        • Owens R.C.
        • McGowan Jr., J.E.
        • Gerding D.N.
        • Weinstein R.A.
        • Burke J.P.
        • et al.
        Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.
        Clin Infect Dis. 2007; 44: 159-177
        • Maragakis L.L.
        • Perencevich E.N.
        • Cosgrove S.E.
        Clinical and economic burden of antimicrobial resistance.
        Expert Rev Anti Infect Ther. 2008; 6: 751-763
        • Carling P.
        • Fung T.
        • Killion A.
        • Terrin N.
        • Barza M.
        Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years.
        Infect Control Hosp Epidemiol. 2003; 24: 699-706
        • LaRocco Jr., A.
        Concurrent antibiotic review programs: a role for infectious diseases specialists at small community hospitals.
        Clin Infect Dis. 2003; 37: 742-743
        • Ruttimann S.
        • Keck B.
        • Hartmeier C.
        • Maetzel A.
        • Bucher H.C.
        Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital.
        Clin Infect Dis. 2004; 38: 348-356
        • Philmon C.
        • Smith T.
        • Williamson S.
        • Goodman E.
        Controlling use of antimicrobials in a community teaching hospital.
        Infect Control Hosp Epidemiol. 2006; 27: 239-244
        • Johannsson B.
        • Beekmann S.E.
        • Srinivasan A.
        • Hersh A.L.
        • Laxminarayan R.
        • Polgreen P.M.
        Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers.
        Infect Control Hosp Epidemiol. 2011; 32: 367-374
        • Dubberke E.R.
        • Reske K.A.
        • McDonald L.C.
        • Fraser V.J.
        ICD-9 codes and surveillance for Clostridium difficile–associated disease.
        Emerg Infect Dis. 2006; 12: 1576-1579
        • Scheurer D.B.
        • Hicks L.S.
        • Cook E.F.
        • Schnipper J.L.
        Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort.
        Epidemiol Infect. 2007; 135: 1010-1013
        • Charlson M.E.
        • Pompei P.
        • Ales K.L.
        • MacKenzie C.R.
        A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
        J Chronic Dis. 1987; 40: 373-383
        • Valiquette L.
        • Cossette B.
        • Garant M.P.
        • Diab H.
        • Pepin J.
        Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile–associated disease caused by the hypervirulent NAP1/027 strain.
        Clin Infect Dis. 2007; 45: S112-S121
        • Dubberke E.R.
        • Wertheimer A.I.
        Review of current literature on the economic burden of Clostridium difficile infection.
        Infect Control Hosp Epidemiol. 2009; 30: 57-66
        • Cohen S.H.
        • Gerding D.N.
        • Johnson S.
        • Kelly C.
        • Loo V.
        • McDonald C.
        • et al.
        Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA).
        Infect Control Hosp Epidemiol. 2010; 31: 431-455
        • Dubberke E.R.
        • Butler A.M.
        • Yokoe D.S.
        • Mayer J.
        • Hota B.
        • Mangino J.E.
        • et al.
        Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes.
        Infect Control Hosp Epidemiol. 2010; 31: 262-268